---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-11T23:22:02.393373'
end_time: '2026-01-11T23:29:00.134429'
duration_seconds: 417.74
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: NEUROG1
  gene_symbol: NEUROG1
  uniprot_accession: Q92886
  protein_description: 'RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class
    A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix
    protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;'
  gene_info: Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359);
    HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 32
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q92886
- **Protein Description:** RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;
- **Gene Information:** Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "NEUROG1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'NEUROG1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **NEUROG1** (gene ID: NEUROG1, UniProt: Q92886) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q92886
- **Protein Description:** RecName: Full=Neurogenin-1; Short=NGN-1; AltName: Full=Class A basic helix-loop-helix protein 6; Short=bHLHa6; AltName: Full=Neurogenic basic-helix-loop-helix protein; AltName: Full=Neurogenic differentiation factor 3; Short=NeuroD3;
- **Gene Information:** Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); HLH (PF00010)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "NEUROG1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'NEUROG1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **NEUROG1** (gene ID: NEUROG1, UniProt: Q92886) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity verification: The target is human NEUROG1 (neurogenin-1), a proneural basic helix-loop-helix (bHLH) transcription factor used extensively to induce neuronal differentiation in human pluripotent stem cells, consistent with the UniProt entry Q92886 and aliases such as NEUROG1/NGN1. Recent human iPSC studies explicitly use inducible NEUROG1/NEUROG2 to drive neuronal fate, supporting identity and function as a bHLH neurogenic TF (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).

1) Key concepts and definitions
- Molecular class: NEUROG1 is a proneural bHLH transcription factor that initiates neuronal differentiation programs. Its canonical role in human cells is demonstrated by inducible NEUROG1/NEUROG2 systems that rapidly convert human iPSCs into neurons and remodel transcriptome and chromatin accessibility during early induction (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- Developmental positioning: In auditory system development, progenitors and precursors that generate spiral ganglion neurons (SGNs) depend on early expression of Eya1/Six1/Sox2 and Neurog1, with NEUROD1, Isl1, and Pou4f1 downstream, situating NEUROG1 at the top of the SGN neurogenic cascade (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).

2) Mechanism of action and pathways
- Primary function: As a bHLH TF, NEUROG1 acts as a transcriptional regulator that initiates neuronal fate and activates downstream neurogenic programs, including NEUROD1. Inner ear neurogenesis requires inhibition of Sox2 by NEUROG1 and NEUROD1, highlighting a mechanistic axis where NEUROG1 relieves prosensory maintenance to promote neural differentiation (Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425) (shah2024moderninvitro pages 11-13). In auditory development, NEUROG1 leads to activation of Neurod1, consistent with a conserved proneural-to-neuronal differentiation sequence (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).
- Signaling pathway integration: During otic placode formation and neurogenesis, Wnt signals regulate fate decisions between otic placode and epidermis; Notch signaling modulates and augments patterning; BMP participates in coordinating central and peripheral neurogenesis—mechanistic contexts in which NEUROG1 functions as the proneural driver (Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425; Nov 2024, Development review of inner ear organoids referencing Wnt/BMP integration) (shah2024moderninvitro pages 11-13, rumbo2024cellulardiversityof pages 7-8).

3) Biological roles, downstream programs, and localization
- Tissues/lineages: NEUROG1 is required for development of peripheral sensory neurons, notably cranial/otic sensory ganglia and SGNs. In the auditory system, NEUROG1 sits upstream of NEUROD1 and is essential for SGN differentiation and wiring programs (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23). Reviews and organoid analyses in 2024 highlight NEUROG1+ immature neurons in human inner ear organoids, reflecting early neuroblast states consistent with placodal lineages (Nov 2024, Development; URL: https://doi.org/10.1242/dev.202524) (rumbo2024cellulardiversityof pages 7-8).
- Downstream transcriptional program: NEUROD1 is a key downstream effector of NEUROG1 in otic and central auditory development; genetic and schema evidence place Neurod1 immediately downstream of Neurog1 to consolidate neuronal differentiation (Aug 2024, Annual Review of Neuroscience; URL: https://doi.org/10.1146/annurev-neuro-081423-093942; Apr 2024, Bioengineering; URL: https://doi.org/10.3390/bioengineering11050425) (pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13).
- Subcellular localization: Functional studies leveraging inducible NEUROG1/2 in human iPSCs demonstrate NEUROG1 acts as a nuclear transcriptional regulator that reprograms expression and accessibility early after induction, consistent with nuclear localization and chromatin regulatory activity of proneural bHLH TFs (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).

4) Recent developments and latest research (2023–2024 prioritized)
- Human iPSC directed differentiation and reprogramming
  - Inducible NEUROG1/NEUROG2 systems in human iPSCs map early transcriptional and chromatin changes and identify essential co-regulators for neuronal differentiation in pooled TF CRISPR screens, consolidating NEUROG1’s role as an entry-point transcription factor for human neuronal programming (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
  - Human inner ear organoids: single-cell and protocol advances in 2024 report neural populations including NEUROG1+ immature neurons within human inner ear organoids, aligning with placode-derived neurogenesis and offering a platform to study NEUROG1-driven states (Nov 2024, Development; URL: https://doi.org/10.1242/dev.202524) (rumbo2024cellulardiversityof pages 7-8).
  - Protocols for sensory ganglia/organoid differentiation show high expression and primer usage for NEUROG1/NEUROG2 in visceral sensory ganglion organoids from iPSCs, underscoring practical use of NEUROG1 as a developmental marker and driver (Oct 2024, Nature Methods; URL: https://doi.org/10.1038/s41592-024-02455-8) (ahn2024differentiatingvisceralsensory pages 16-22).
- Auditory system development: A 2024 Annual Review synthesizes gene networks placing NEUROG1 upstream in SGN lineage commitment, with NEUROD1 downstream, and integrates transcriptional programs across the auditory pathway (Aug 2024; URL: https://doi.org/10.1146/annurev-neuro-081423-093942) (pyott2024harmonyinthe pages 19-23).

5) Current applications and real-world implementations
- Cancer epigenetics and diagnostics: NEUROG1 promoter methylation is part of CpG island methylator phenotype (CIMP) marker panels used in colorectal cancer (CRC) research/stratification.
  - A 2024 translational study in rhesus macaques developing a methylation-specific qPCR panel based on human CIMP markers explicitly included NEUROG1 (with MLH1, CACNA1G, CDKN2A, CRABP1) to assess CIMP status; 9/16 tumors were CIMP-positive and all 16/16 exhibited MLH1 promoter hypermethylation (Mar 2024, Journal of Translational Medicine; URL: https://doi.org/10.1186/s12967-024-04869-6) (deycmar2024epigeneticmlh1silencing pages 10-13).
  - A 2024 analysis of synchronous vs solitary primary CRCs reports higher methylation rates for markers including CACNA1G and NEUROG1 in CIMP-positive disease and surveys therapy implications by CIMP status (May 2024, International Journal of Molecular Sciences; URL: https://doi.org/10.3390/ijms25105243) (weng2024thecpgisland pages 8-10).
  - Systematic and clinical reviews in 2024 highlight the maturing landscape of blood-based methylated DNA assays for CRC screening (SEPT9, SDC2 and multi-marker panels), contextualizing where NEUROG1 panels fit among validated and investigational assays; such reviews summarize sensitivity/specificity ranges and emphasize multi-marker strategies for stage I/II detection (Jul 2024, Gastroenterology and Hepatology From Bed to Bench; URL: https://doi.org/10.22037/ghfbb.v17i3.2978; Apr 2024, Intestinal Research; URL: https://doi.org/10.5217/ir.2023.00115) (khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

6) Human disease associations
- Congenital cranial dysinnervation disorder (CCDD) due to biallelic NEUROG1 variants: A 2023 case report describes two siblings with a novel homozygous truncating NEUROG1 variant (c.228_231dup; p.Thr78ProfsTer122) presenting with global developmental delay, autism spectrum disorder, hearing loss, corneal opacity, absent corneal reflex, and cranial nerve abnormalities; this is the fourth reported family worldwide linking biallelic NEUROG1 variants to cranial dysinnervation phenotypes (Jan 2023, BMC Neurology; URL: https://doi.org/10.1186/s12883-023-03065-1) (sheth2023anovelcase pages 2-5).

7) Relevant statistics and data
- iPSC neuronal programming: NEUROG1/2 induction in human iPSCs triggers measurable transcriptome and chromatin accessibility changes within 12 hours; the study integrates RNA-seq/ATAC-seq and TFome-wide CRISPR screening to identify essential downstream TFs for NEUROG1-driven differentiation (Dec 2023, Nature Communications; URL: https://doi.org/10.1038/s41467-023-43602-7) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- CIMP/CRC panels involving NEUROG1:
  - In rhesus CRCs assessed with a methylation-specific qPCR panel based on human CIMP markers (including NEUROG1), 9/16 tumors were CIMP-positive; 16/16 had MLH1 promoter hypermethylation (Mar 2024, Journal of Translational Medicine; URL: https://doi.org/10.1186/s12967-024-04869-6) (deycmar2024epigeneticmlh1silencing pages 10-13).
  - Clinical review indicates CIMP-positive CRCs exhibit distinct therapeutic and prognostic behaviors; methylation of markers such as CACNA1G and NEUROG1 is elevated in CIMP-positive groups and may influence responses to 5-FU, irinotecan, and EGFR-targeted therapies, though results can be context-dependent and require further validation (May 2024, International Journal of Molecular Sciences; URL: https://doi.org/10.3390/ijms25105243) (weng2024thecpgisland pages 8-10).
- Biomarker performance landscape: Blood-based methylated ctDNA assays show promising sensitivity for early CRC with single markers (e.g., SEPT9, SDC2) and improved performance with multi-marker panels; stage I/II detection is feasible though standardization and large multicenter validation remain needs (Jul 2024, Gastroenterology and Hepatology From Bed to Bench; URL: https://doi.org/10.22037/ghfbb.v17i3.2978; Apr 2024, Intestinal Research; URL: https://doi.org/10.5217/ir.2023.00115) (khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

8) Expert opinion and analysis
- Functional annotation: Human studies firmly position NEUROG1 as an initiating proneural bHLH transcription factor that activates neuronal programs (e.g., NEUROD1) and reconfigures chromatin in early differentiation—a role that is mechanistically conserved from development and is directly harnessed in human iPSC models (Dec 2023, Nature Communications) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13).
- Developmental specificity: In the auditory system, NEUROG1 functions upstream in SGN lineage commitment, integrating with placodal gene networks; deficits in NEUROG1 or downstream NEUROD1 perturb auditory circuit formation and tonotopic projections, underscoring their hierarchy in sensory neurogenesis (Aug 2024, Annual Review of Neuroscience) (pyott2024harmonyinthe pages 19-23).
- Translational trajectory: NEUROG1 promoter methylation belongs to widely used CIMP panels; although not yet a standalone clinical companion diagnostic, its inclusion in research-grade panels and comparative oncology models (rhesus) supports analytical validity and biological relevance in CRC stratification, while blood-based methylation screening is rapidly maturing with multi-marker strategies (Mar 2024, Journal of Translational Medicine; May 2024, IJMS; Jul 2024, GHFBB; Apr 2024, Intestinal Research) (deycmar2024epigeneticmlh1silencing pages 10-13, weng2024thecpgisland pages 8-10, khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

Limitations and remaining gaps
- While bHLH domain properties (E-box CANNTG recognition, E-protein dimerization) are canonical, the 2023–2024 sources above focus on functional genomics and developmental context rather than biochemical detail; nonetheless, the human reprogramming and auditory development literature cited provides strong evidence for NEUROG1’s role as a nuclear bHLH transcriptional activator leading to NEUROD1 programs and sensory neuron differentiation (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13, pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13).

Summary
Human NEUROG1 (NGN1) is a proneural bHLH transcription factor that acts in the nucleus to initiate neuronal differentiation, prominently activating NEUROD1 and neurogenic programs. It is essential for cranial sensory/otic lineages including SGNs and integrates within Wnt/Notch/BMP-modulated developmental contexts. Modern human iPSC systems use inducible NEUROG1/2 to rapidly program neurons, and organoid studies reveal NEUROG1+ immature neurons mirroring human inner ear development. Clinically, NEUROG1 promoter methylation is incorporated into CIMP marker panels for CRC stratification and is being explored alongside other methylated DNA biomarkers for early cancer detection and therapeutic guidance (Dec 2023–Nov 2024 sources) (lu2023essentialtranscriptionfactors pages 11-12, lu2023essentialtranscriptionfactors pages 12-13, pyott2024harmonyinthe pages 19-23, shah2024moderninvitro pages 11-13, rumbo2024cellulardiversityof pages 7-8, ahn2024differentiatingvisceralsensory pages 16-22, deycmar2024epigeneticmlh1silencing pages 10-13, weng2024thecpgisland pages 8-10, khabbazpour2024advancesinblood pages 11-12, oh2024pathogenesisandbiomarkers pages 14-16).

References

1. (lu2023essentialtranscriptionfactors pages 11-12): Congyi Lu, Görkem Garipler, Chao Dai, Timothy Roush, Jose Salome-Correa, Alex Martin, Noa Liscovitch-Brauer, Esteban O. Mazzoni, and Neville E. Sanjana. Essential transcription factors for induced neuron differentiation. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43602-7, doi:10.1038/s41467-023-43602-7. This article has 36 citations and is from a highest quality peer-reviewed journal.

2. (lu2023essentialtranscriptionfactors pages 12-13): Congyi Lu, Görkem Garipler, Chao Dai, Timothy Roush, Jose Salome-Correa, Alex Martin, Noa Liscovitch-Brauer, Esteban O. Mazzoni, and Neville E. Sanjana. Essential transcription factors for induced neuron differentiation. Nature Communications, Dec 2023. URL: https://doi.org/10.1038/s41467-023-43602-7, doi:10.1038/s41467-023-43602-7. This article has 36 citations and is from a highest quality peer-reviewed journal.

3. (pyott2024harmonyinthe pages 19-23): Sonja J. Pyott, Gabriela Pavlinkova, Ebenezer N. Yamoah, and Bernd Fritzsch. Harmony in the molecular orchestra of hearing: developmental mechanisms from the ear to the brain. Annual Review of Neuroscience, 47:1-20, Aug 2024. URL: https://doi.org/10.1146/annurev-neuro-081423-093942, doi:10.1146/annurev-neuro-081423-093942. This article has 30 citations and is from a domain leading peer-reviewed journal.

4. (shah2024moderninvitro pages 11-13): Jamie J. Shah, Couger A. Jimenez-Jaramillo, Zane R. Lybrand, Tony T. Yuan, and Isaac D. Erbele. Modern in vitro techniques for modeling hearing loss. Bioengineering, 11:425, Apr 2024. URL: https://doi.org/10.3390/bioengineering11050425, doi:10.3390/bioengineering11050425. This article has 3 citations and is from a poor quality or predatory journal.

5. (rumbo2024cellulardiversityof pages 7-8): Mireia Rumbo and Berta Alsina. Cellular diversity of human inner ear organoids revealed by single-cell transcriptomics. Development, Nov 2024. URL: https://doi.org/10.1242/dev.202524, doi:10.1242/dev.202524. This article has 3 citations and is from a domain leading peer-reviewed journal.

6. (ahn2024differentiatingvisceralsensory pages 16-22): Kyusik Ahn, Hwee-Seon Park, Sieun Choi, Hojeong Lee, Hyunjung Choi, Seok Beom Hong, Jihui Han, Jong Won Han, Jinchul Ahn, Jaehoon Song, Kyunghyuk Park, Bukyung Cha, Minseop Kim, Hui-Wen Liu, Hyeonggyu Song, Sang Jeong Kim, Seok Chung, Jong-Il Kim, and Inhee Mook-Jung. Differentiating visceral sensory ganglion organoids from induced pluripotent stem cells. Nature methods, 21:2135-2146, Oct 2024. URL: https://doi.org/10.1038/s41592-024-02455-8, doi:10.1038/s41592-024-02455-8. This article has 7 citations and is from a highest quality peer-reviewed journal.

7. (deycmar2024epigeneticmlh1silencing pages 10-13): Simon Deycmar, Brendan J. Johnson, Karina Ray, George W. Schaaf, Declan Patrick Ryan, Cassandra Cullin, Brandy L. Dozier, Betsy Ferguson, Benjamin N. Bimber, John D. Olson, David L. Caudell, Christopher T. Whitlow, Kiran Kumar Solingapuram Sai, Emily C. Romero, Francois J. Villinger, Armando G. Burgos, Hannah C. Ainsworth, Lance D. Miller, Gregory A. Hawkins, Jeff W. Chou, Bruno Gomes, Michael Hettich, Maurizio Ceppi, Jehad Charo, and J. Mark Cline. Epigenetic mlh1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques. Journal of Translational Medicine, Mar 2024. URL: https://doi.org/10.1186/s12967-024-04869-6, doi:10.1186/s12967-024-04869-6. This article has 6 citations and is from a peer-reviewed journal.

8. (weng2024thecpgisland pages 8-10): Yun-Yun Weng and Ming-Yii Huang. The cpg island methylator phenotype status in synchronous and solitary primary colorectal cancers: prognosis and effective therapeutic drug prediction. International Journal of Molecular Sciences, 25:5243, May 2024. URL: https://doi.org/10.3390/ijms25105243, doi:10.3390/ijms25105243. This article has 4 citations and is from a poor quality or predatory journal.

9. (khabbazpour2024advancesinblood pages 11-12): Milad Khabbazpour, Masoud Tat, Ashraf Karbasi, M. Abyazi, Ghazal Khodadoustan, Zohreh Heidary, and Majid Zaki-Dizaji. Advances in blood dna methylation-based assay for colorectal cancer early detection: a systematic updated review. Gastroenterology and Hepatology From Bed to Bench, 17:225-240, 2024. URL: https://doi.org/10.22037/ghfbb.v17i3.2978, doi:10.22037/ghfbb.v17i3.2978. This article has 10 citations and is from a peer-reviewed journal.

10. (oh2024pathogenesisandbiomarkers pages 14-16): Chang Kyo Oh and Young-Seok Cho. Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration. Intestinal Research, 22:131-151, Apr 2024. URL: https://doi.org/10.5217/ir.2023.00115, doi:10.5217/ir.2023.00115. This article has 19 citations and is from a peer-reviewed journal.

11. (sheth2023anovelcase pages 2-5): Frenny Sheth, Jhanvi Shah, Ketan Patel, Darshan Patel, Deepika Jain, Jayesh Sheth, and Harsh Sheth. A novel case of two siblings harbouring homozygous variant in the neurog1 gene with autism as an additional phenotype: a case report. BMC Neurology, Jan 2023. URL: https://doi.org/10.1186/s12883-023-03065-1, doi:10.1186/s12883-023-03065-1. This article has 3 citations and is from a peer-reviewed journal.

## Citations

1. pyott2024harmonyinthe pages 19-23
2. shah2024moderninvitro pages 11-13
3. rumbo2024cellulardiversityof pages 7-8
4. ahn2024differentiatingvisceralsensory pages 16-22
5. weng2024thecpgisland pages 8-10
6. sheth2023anovelcase pages 2-5
7. lu2023essentialtranscriptionfactors pages 11-12
8. lu2023essentialtranscriptionfactors pages 12-13
9. khabbazpour2024advancesinblood pages 11-12
10. oh2024pathogenesisandbiomarkers pages 14-16
11. https://doi.org/10.1038/s41467-023-43602-7
12. https://doi.org/10.1146/annurev-neuro-081423-093942
13. https://doi.org/10.3390/bioengineering11050425
14. https://doi.org/10.3390/bioengineering11050425;
15. https://doi.org/10.1242/dev.202524
16. https://doi.org/10.1146/annurev-neuro-081423-093942;
17. https://doi.org/10.1038/s41592-024-02455-8
18. https://doi.org/10.1186/s12967-024-04869-6
19. https://doi.org/10.3390/ijms25105243
20. https://doi.org/10.22037/ghfbb.v17i3.2978;
21. https://doi.org/10.5217/ir.2023.00115
22. https://doi.org/10.1186/s12883-023-03065-1
23. https://doi.org/10.1038/s41467-023-43602-7,
24. https://doi.org/10.1146/annurev-neuro-081423-093942,
25. https://doi.org/10.3390/bioengineering11050425,
26. https://doi.org/10.1242/dev.202524,
27. https://doi.org/10.1038/s41592-024-02455-8,
28. https://doi.org/10.1186/s12967-024-04869-6,
29. https://doi.org/10.3390/ijms25105243,
30. https://doi.org/10.22037/ghfbb.v17i3.2978,
31. https://doi.org/10.5217/ir.2023.00115,
32. https://doi.org/10.1186/s12883-023-03065-1,